<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The aim of this study is to investigate the effects of <z:chebi fb="0" ids="2979">baicalein</z:chebi> on <z:hpo ids='HP_0100543'>cognitive impairment</z:hpo> and <z:mp ids='MP_0002229'>neuronal degeneration</z:mp> in a rat model of <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C1695782" disease_type="Disease or Syndrome" abbrv="">cerebral hypoperfusion</z:e> induced by permanent occlusion of bilateral common carotid arteries (2VO) </plain></SENT>
<SENT sid="1" pm="."><plain>It was found that <z:chebi fb="0" ids="2979">baicalein</z:chebi> (2 or 4 mg/kg/day, i.p.) significantly improved 2VO-induced <z:hpo ids='HP_0100543'>cognitive deficits</z:hpo> and neuropathological changes </plain></SENT>
<SENT sid="2" pm="."><plain>Biochemical and histological examinations revealed that <z:chebi fb="0" ids="2979">baicalein</z:chebi> reduced the increased activities of <z:chebi fb="1" ids="18421">superoxide</z:chebi> dismutase (SOD) and malondialdehyde (<z:chebi fb="14" ids="32506">MDA</z:chebi>), and attenuated the decreased activities of <z:chebi fb="0" ids="16856">glutathione</z:chebi> peroxidase (GPx) and catalase in 2VO rats </plain></SENT>
<SENT sid="3" pm="."><plain>The results of the present observation suggest that <z:chebi fb="0" ids="2979">baicalein</z:chebi> has therapeutic potential for the treatment of vascular <z:hpo ids='HP_0000726'>dementia</z:hpo>, which is most likely related, at least in part, to its <z:chebi fb="11" ids="22586">antioxidant</z:chebi> action </plain></SENT>
</text></document>